Cargando…

Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature

Background: Hepatocellular Carcinoma (HCC) represents the fifth most common malignancy and the third cancer-related cause of death worldwide. Hepatitis B (HBV) and C (HCV) viral infections and alcohol abuse are the principal etiological factors for HCC. Liver transplantation (LT) is oncologically th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarantino, Giuseppe, Magistri, Paolo, Ballarin, Roberto, Di Francia, Raffaele, Berretta, Massimiliano, Di Benedetto, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073152/ https://www.ncbi.nlm.nih.gov/pubmed/27818634 http://dx.doi.org/10.3389/fphar.2016.00387

Ejemplares similares

Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Robotic liver surgery is the optimal approach as bridge to transplantation
por: Magistri, Paolo, et al.
Publicado: (2017)

Extra-Anatomic Jump Graft from the Right Colic Vein: A Novel Technique to Manage Portal Vein Thrombosis in Liver Transplantation
por: Magistri, Paolo, et al.
Publicado: (2018)

Liver Transplantation for HCC in HIV-Infected Patients: Long-Term Single-Center Experience
por: Guerrini, Gian Piero, et al.
Publicado: (2021)

Salvage versus Primary Liver Transplantation for Hepatocellular Carcinoma: A Twenty-Year Experience Meta-Analysis
por: Guerrini, Gian Piero, et al.
Publicado: (2022)

Improving Outcomes Defending Patient Safety: The Learning Journey in Robotic Liver Resections
por: Magistri, Paolo, et al.
Publicado: (2019)

Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017)

Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors
por: Ballarin, Roberto, et al.
Publicado: (2017)

Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection
por: Berretta, Massimiliano, et al.
Publicado: (2016)

A new peg-filgrastim biosimilar, mecapegfilgrastim for primary prophylaxis of chemotherapy-related neutropenia is now available
por: Tirelli, Umberto, et al.
Publicado: (2020)

A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients
por: Guaraldi, Giovanni, et al.
Publicado: (2017)

Perihilar-cholangiocarcinoma: what really matters?
por: Di Benedetto, Fabrizio, et al.
Publicado: (2022)

Liver transplantation: immunosuppression and oncology
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2014)

Laparoscopic Management of Blunt Pancreatic Trauma in Adults and Pediatric Patients: A Systematic Review
por: Catellani, Barbara, et al.
Publicado: (2023)

Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
por: Maximova, Natalia, et al.
Publicado: (2022)

SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
por: Magistri, Paolo, et al.
Publicado: (2018)

Robotic liver partition and portal vein embolization for staged hepatectomy for perihilar cholangiocarcinoma
por: Di Benedetto, Fabrizio, et al.
Publicado: (2021)

Pharmacogenetic-Based Interactions between Nutraceuticals and Angiogenesis Inhibitors
por: Di Francia, Raffaele, et al.
Publicado: (2019)

Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Clinical Implications of Malnutrition in the Management of Patients with Pancreatic Cancer: Introducing the Concept of the Nutritional Oncology Board
por: Rovesti, Giulia, et al.
Publicado: (2021)

Liver transplantation for iatrogenic injuries secondary to cholecystectomy: a systematic review
por: Guidetti, Cristiano, et al.
Publicado: (2023)

Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression Microenvironment
por: Cheng, Changpei, et al.
Publicado: (2020)

Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress
por: Cocetta, Veronica, et al.
Publicado: (2021)

An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project
por: Belleudi, Valeria, et al.
Publicado: (2022)

Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results
por: Magistri, Paolo, et al.
Publicado: (2020)

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies
por: Berretta, Massimiliano, et al.
Publicado: (2018)

mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
por: Granata, Simona, et al.
Publicado: (2021)

Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant
por: Sung, Pil Soo, et al.
Publicado: (2021)

Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma
por: Di Marco, Lorenza, et al.
Publicado: (2023)

Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies
por: Nascimento, Guilherme Fagundes, et al.
Publicado: (2020)

Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study
por: Shafiekhani, Mojtaba, et al.
Publicado: (2023)

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)
por: Girardin, François R., et al.
Publicado: (2023)

Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016)

Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”
por: Cecere, Sabrina C., et al.
Publicado: (2016)

Corrigendum: Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”
por: Cecere, Sabrina C., et al.
Publicado: (2016)

Common bile duct lesions - how cholangioscopy helps rule out intraductal papillary neoplasms of the bile duct: A case report
por: Cocca, Silvia, et al.
Publicado: (2020)

Identification of Immunosuppressive Medication Nonadherence Factors Through a Combined Theory Model in Renal Transplant Recipients: 6–12
por: Zhang, Pengpeng, et al.
Publicado: (2021)

Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H(22) Hepatocellular Carcinoma-Bearing Mice: By Targeting Myeloid-Derived Suppressor Cells
por: Xie, Yingjie, et al.
Publicado: (2020)

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
por: Campos-Salazar, Antony Brayan, et al.
Publicado: (2018)

Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature
por: Berretta, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vbcai5amijoeu705c11esnbh9b